Serum Amyloid A (SAA) — The Precursor of Protein AA in Secondary Amyloidosis

  • G. Husby
  • A. Husebekk
  • B. Skogen
  • K. Sletten
  • G. Marhaug
  • J. Magnus
  • V. Syversen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 243)


In 1968, Prasandco-workers (1) published the water extraction technique which has become the standard method for purification of amyloidfibrils. Subsequent gel filtration of dissociated fibrils obtained from different clinical and experimental types of amyloidosis has in many instances revealed an elution pattern consisting of two main protein peaks (2). The second of these peaks represents a protein with molecular weight ranging from 4.2 to 31 kD in different amyloid preparations (2). It is the recognition and characterization of this low molecular weight amyloid protein that has enabled a chemical and immunologic classification of amyloid fibrils (2,3). It has been shown that different, apparently non related proteins can constitute the fibrils sub unit is different cases of amyloidosis. Moreover, the nature of the protein is in most cases related to specific clinical types of amyloidosis (2,3). Certain serum proteins are precursors for the different fibril proteins in the various systemic forms of amyloidosis (2,3). Two important fibril proteins related to systemic amyloidosis are the amyloidL (AL) and amyloid A (AA) proteins. Protein AL, which consists of homogenous (monoclonal) immunoglobulin kappa or lambda light chains or fragments thereof (2,3) are seen in primary (idiopathic) and myeloma-associated amyloidosis (ALamyloidosis). Protein AA is associated with secondary (reactive) amyloidosis, the recessively inherited familial Mediterranean fever (FMF), and spontaneous and experi-mental amyloidosis in animals (2,3). These forms of amyloidosis can there-fore, also be called AA amyloidosis. This presentation will concentrate on protein AA and its serum precursor SAA.


Familial Mediterranean Fever Amyloid Fibril Serum Amyloid Amyloid Protein Secondary Amyloidosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Pras, M. Schubert, D. Zucker-Franklin, A. Rimonand,E.G. Franklin, The characterization of soluble amyloid prepared in water. J. Clin. Invest. 47:923 (1968)Google Scholar
  2. 2.
    G. Husby and K. Sletten, Chemical and clinical classification of amyloid 1985. Scand. J. Immunol. 23:253 (1986)PubMedCrossRefGoogle Scholar
  3. 3.
    G.G. Glenner, Amyloid deposits and amyloidosis. N. Engl. J. Med. 302:1283,1333 (1980)Google Scholar
  4. 4.
    E.P. Benditt, M. Eriksen, M.A. Hermodsen and L.H. Ericsson, The major proteins of human and monkey amyloid substance :common properties including unusual N-terminal amino acid sequences. FEBS lett.19:169 (1971)PubMedCrossRefGoogle Scholar
  5. 5.
    A. Husebekk, B. Skogen, G. Husby and G. Marhaug, Transformation of amyloid precursor SAA to protein AA and in corporation in amyloid fibrils in vivo. Scand. J. Immunol. 21:283 (1985)PubMedCrossRefGoogle Scholar
  6. 6.
    A. Husebekk, B. Skogen and G. Husby, Both SAA and AA are associated with HDL in human serum. Protides of the Biological Fluids (Ed.H.Peters), 34: 367 (1986)Google Scholar
  7. 7.
    A. Husebekk, B. Skogen and G. Husby, Characterization of amyloid proteins AA and SAA as apolipoproteins of HDL. Displacement of SAA from the HDL-SAA by apo Alandapo All. Scand. J. Immunol. 25:375 (1987).PubMedCrossRefGoogle Scholar
  8. 8.
    M,L. Baltz, I.F. Rowe, D. Caspi, W.G. Turnell and M.B. Pepys, Is the serum amyloid A protein in acute phase plasma high-density lipoprotein the precursor of AA fibrils?ClinExp. Immunol. 66:701 (1986)PubMedGoogle Scholar
  9. 9.
    C. Tape, R. Tan, M. Nesheim and R. Kisilevski, Apo SAA andA A: Precursor and product revisited. In Proceedings of the Vth International Symposium on Amyloidosis, Hakone, Japan (1987)Google Scholar
  10. 10.
    K. Sletten and G. Husby, The complete amino acid sequence of non immunoglobul in amyloid fibril protein AS in rheumatoidarthritis. Eur. J. Biochem.41:117 (1974)PubMedCrossRefGoogle Scholar
  11. 11.
    K. Sletten, G. Marhaug and G. Husby, The covalent structure of amyloid related serum protein SAA from two patients with inflammatory disease. Hoppe-Zeyler’s Z. Physiol. Chem. 364:1039 (1983)CrossRefGoogle Scholar
  12. 12.
    D.C. Parmelee, K. Titani, L.H. Ericsson, N. Eriksen, E.P. Benditt and K.A. Walsh, Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human HDL. Biochemistry 21:3298 (1982)PubMedCrossRefGoogle Scholar
  13. 13.
    G. Hursby and K. Sletten, Amyloidproteins. Pp23–24 In J. Marrink and M.H. van Rijswijk (Eds). Amyloidosis. Martinus Nijhoff Publishers, Dordrecht (1986)CrossRefGoogle Scholar
  14. 14.
    G.T. Westermark, P. Westermark, K. Sletten, Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoidarthritis. Lab.Invest. 57:57 (1987)PubMedGoogle Scholar
  15. 15.
    L.H. Ericsson, N.Eriksen, K.A.Walsh and E.P. Benditt, Primary struc-ture of duck amyloid protein A. FEBS LETT, 218:11 (1987)PubMedCrossRefGoogle Scholar
  16. 16.
    A. Husebekk, G. Husby, K. Sletten, G. Marhaug and K. Nordstoga, Characterization of amyloid protein AA and its serum precursor SAA in the horse. Scand. J. Immunol. 23:703 (1986)PubMedCrossRefGoogle Scholar
  17. 17.
    W. Turnell, R. Sarra, I.D. Glover, J.O. Baum, D. Caspi, M.L. Baltz and M.D. Pepys, Secondary structure prediction of human SAA 1. Presumtive identification of calcium and lipid binding sites. Mol. Biol. Med. 3:387 (1986)PubMedGoogle Scholar
  18. 18.
    W. Turnell, R. Sarra, J.O. Baum, D. Caspi, M.L. Baltz and M.B. Pepys, X-rays cattering and diffraction by wetgels of AA amyloid fibrils. Mol. Biol. Med. 3:409 (1986)PubMedGoogle Scholar
  19. 19.
    K. Waalen, K. Sletten, G. Husby and K. Nordstoga, The primary structure of amyloid fibril protein AA in endotoxin-induced amyloidosis of the mink. Eur. J. Biochem. 104:407 (1980)PubMedCrossRefGoogle Scholar
  20. 20.
    V. Syversen, K. Sletten, G. Marhaug, G. Husby and B. Lium, The amino acid sequence of serum amyloid A (SAA) in mink. Scand. J. Immunol. 26:763 (1987)PubMedCrossRefGoogle Scholar
  21. 21.
    K. Sletten, A. Husebekk and G. Husby, The amino acid sequence of an amyloid fibril protein AA in horse. Scand. J. Immunol. 26:79 (1987)PubMedCrossRefGoogle Scholar
  22. 22.
    G. Marhaug, K. Sletten and G. Husby, Characterization of amyloid related serum protein SAA complexed with serum lipoproteins (apoSAA). Clin. Exp. Immunol. 50:383 (1982)Google Scholar
  23. 23.
    E.P. Benditt and N. Eriksen, Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. USA 74:4025 (1977)PubMedCrossRefGoogle Scholar
  24. 24.
    B. Skogen, A.L. Børresen, J.B. Natvig, K.Bergand T.E. Michaelsen, High-density lipoproteins as carrier for amyloid-related protein SAA in rabbit serum. Scand. J. Immunol. 10:39 (1979)PubMedCrossRefGoogle Scholar
  25. 25.
    G. Marhaug, Three assays for the characterization and quantitation of human serum amyloid A. Scand. J. Immunol. 18:329 (1983)PubMedCrossRefGoogle Scholar
  26. 26.
    K.P.W.J. McAdam, J.Li. J. Knowles, N.T. Foss, C.A. Dinarello, L.J. Rosenwasser, M.J. Selinger, M.M. Kaplan and R. Goodman, The biology of SAA: Identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann. NYA cad. Sci. 389:126 (1982)CrossRefGoogle Scholar
  27. 27.
    M. Pepys, M.L. Baltz, Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34:141 (1983)PubMedCrossRefGoogle Scholar
  28. 28.
    G. Marhaug, H. Permin and G. Husby, Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis. Acta Padiatr. Scand. 72:861 (1983)CrossRefGoogle Scholar
  29. 29.
    A. Husebekk, H. Permin and G. Husby, Serum amyloid protein A (SAA)-an indicator of inflammation in AIDS and AIDS-related complex (ARC). Scand. J. Infect. Pis. 18:389 (1986)CrossRefGoogle Scholar
  30. 30.
    G. Marhaug, L. Harklau, B. Olsen, G. Husby, A. Husebekk and H. Wang, Serum amyloid A protein in acute myocardial infarction, Acta Med. Scand. 220:303 (1986)PubMedCrossRefGoogle Scholar
  31. 31.
    G. Marhaug, M. Østensen, G. Husby S. Kolmannskog, T. Flaegstad, T. Stokland and A. Husebekk, Clinical acute phase pattern of serum amyloid A. Protides of the Biological Fluids (Ed.H.Peters) 34:375 (1986)Google Scholar
  32. 32.
    A. Husebekk, B. Skogen and G. Husby, Replacement of SAA from the HDL-SAA complex by apo AI and apo All. In: Proceedings of the Vth International Symposiumon Amyloidosis, Hakone, Japan (1987)Google Scholar
  33. 33.
    J.S. Park and L.L. Rudel, Alteration of high density lipoprotein subfraction distribution with induction of serum amyloid A protein (SAA) in the non-human primate. J. Lip. Res. 26:82 (1985)Google Scholar
  34. 34.
    G.A. Coetzee, A.F. Strachan, D.R. vander Westhuyzen, H.C. Hoppe, M.S. Jeenan and F.C. deBeer, Serum amyloidA- containing human high density lipoproteins. J. Biol. Chem. 261:9644 (1986)PubMedGoogle Scholar
  35. 35.
    R.F. Anders, J.B. Natvig, K. Sletten, G. Husby and K. Nordstoga, Amyloid related serum protein SAA from three animal species: Comparison with human SAA.J. Immunol. 118:229 (1977)PubMedGoogle Scholar
  36. 36.
    J.D. Sipe, H.R. Colten, G. Goldberger, M.D. Edge, B.F. Tack, A.S. Cohen and A.S. Whitehead, Human serum amyloid A (SAA): Biosynthesis and post synthetic processing of pre SAA and structural variants defined by complementary DNA. Biochemistry, 24:2931 (1985)PubMedCrossRefGoogle Scholar
  37. 37.
    K.-I. Yamamoto, M. Shiroo and S. Migita, Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction Science, 232:227 (1986)PubMedCrossRefGoogle Scholar
  38. 38.
    B. Kluve- Beckerman, G.L. Long and M.D. Benson, DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA) Biochem. Genet. 24:795 (1986)PubMedCrossRefGoogle Scholar
  39. 39.
    P. Woo, J. Sipe, C.A. Dinarello and H.R. Colton, Structure of a human serum amyloid A gene and modulation of its expression intransfected L cells. J. Biol. Chem. 262:1570 (1987)Google Scholar
  40. 40.
    J.S. Hoffman, L.H. Ericsson, N. Eriksen, K.A. Walsh and E.P. Benditt, Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J. Exp. Med., 159:641 (1984)PubMedCrossRefGoogle Scholar
  41. 41.
    R.L. Meek, J.S. Hoffmann and E.P. Benditt, Amyloido genesis. One serum amyloid A isotype is selectively removed from the sirculation. J. Exp. Med. 163:499 (1986)PubMedCrossRefGoogle Scholar
  42. 42.
    M.Levin, E.C. Franklin, B. Frangione and M. Pras, The amino acid sequence of a major non-immunoglobulin component of some amyloid fibrils. J. Clin. Invest. 51:2773 (1972)PubMedCrossRefGoogle Scholar
  43. 43.
    H. Rokita, T. Shirahama, A.S. Cohen, R.L. Meek, E.P. Benditt and J. Sipe, Differential expression of the amyloid SAA 3 gene liver and perinoneal macrophages of mice undergoing dissimilar inflammatory processes. J. Immunol. 139:3849 (1987)PubMedGoogle Scholar
  44. 44.
    A.D. Snow, J. Willmer and R. Kisilevsky, A close structural relation-ship between sulfated proteoglycans and AA amyloid fibrils. Lab. Invest. 57:687 (1987)PubMedGoogle Scholar
  45. 45.
    T.A. Niewold, P.R. Hoi, A.C.J. vanAndel, E.T.G. Lutz and E. Gruys, Enhancement of amyloid induction by amyloid fibril fragments in hamster, Lab. Invest. 56:544 (1987)PubMedGoogle Scholar
  46. 46.
    B. Skogen and J.B. Natvig, Degradation of amyloid proteins by different serine proteases. Scand. J. Immunol.14:389 (1981)PubMedCrossRefGoogle Scholar
  47. 47.
    A. Fuks and D. Zucker-Franklin, Impaired Kuppfer cell function precedes the development of secondary amyloidosis. J. Exp. Med.161:1013 (1985)PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • G. Husby
    • 1
    • 2
  • A. Husebekk
    • 1
    • 2
  • B. Skogen
    • 1
    • 2
  • K. Sletten
    • 1
    • 2
  • G. Marhaug
    • 1
    • 2
  • J. Magnus
    • 1
    • 2
  • V. Syversen
    • 1
    • 2
  1. 1.University Hospital of TromsøTromsøNorway
  2. 2.University of Oslo 3Norway

Personalised recommendations